Skip to main content
Top
Published in: Diabetologia 12/2003

01-12-2003 | Article

Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats

Authors: T. Kitamura, K. Kimura, PhD, K. Makondo, D. T. Furuya, M. Suzuki, T. Yoshida, M. Saito

Published in: Diabetologia | Issue 12/2003

Login to get access

Abstract

Aims/hypothesis

Recent studies have suggested that proinsulin C-peptide improves vascular functions, possibly through nitric oxide (NO) production. To clarify the molecular mechanisms of vascular NO production induced by C-peptide, we examined the effects of C-peptide on NO production and NO synthase expression in rat aortic endothelial cells in connection with mitogen-activated protein kinase (MAPK) activation.

Methods

Aortic endothelial cells were isolated from female Wistar rats, cultured to confluence, and serum-starved for 24 h before treatment with C-peptide. Nitric oxide production was measured by the DAF-2 fluorescence dye method and relative amounts of endothelial nitric oxide synthase (eNOS) protein and its mRNA were semi-quantified by western blot and RT-PCR analyses respectively. Activation of MAPK was estimated by western blot detection of activity-related phosphorylation and in vitro kinase assay.

Results

Stimulation of cells with C-peptide for 3 h doubled NO production, which was suppressed by the NO synthase inhibitor, N G -nitro-L-arginine methyl ester (L-NAME). Stimulation also increased mRNA and protein contents of eNOS in a manner sensitive to the transcription inhibitor actinomycin D. It did not affect inducible NO synthase mRNA. C-peptide also induced rapid phosphorylation and activation of extracellular signal-regulated kinase (ERK, also known as p44/42MAPK), but not of p38MAPK. In cells pretreated with the ERK inhibitor PD98059 the C-peptide-elicited increase of NO production and eNOS was abrogated in a dose-dependent manner; suppression of ERK phosphorylation induced by C-peptide also occurred.

Conclusions/interpretation

Our results show that C-peptide increases NO production by increasing eNOS protein contents through ERK-dependent up-regulation of eNOS gene transcription. This could explain some actions of C-peptide on the vasculature, indicating a pivotal role for C-peptide in vascular homeostasis.
Literature
1.
go back to reference Wahren J, Ekberg K, Johansson J et al. (2000) Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278:E759–E768PubMed Wahren J, Ekberg K, Johansson J et al. (2000) Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278:E759–E768PubMed
2.
go back to reference Johansson BL, Sjoberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35:121–128 Johansson BL, Sjoberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35:121–128
3.
go back to reference Forst T, Kunt T, Pohlmann T et al. (1998) Biological activity of C-peptide on the skin microcirculation in patients with insulin dependent diabetes mellitus. J Clin Invest 101:2036–2041PubMed Forst T, Kunt T, Pohlmann T et al. (1998) Biological activity of C-peptide on the skin microcirculation in patients with insulin dependent diabetes mellitus. J Clin Invest 101:2036–2041PubMed
4.
go back to reference Forst T, De La Tour DD, Kunt T et al. (2000) Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci 98:283–290PubMed Forst T, De La Tour DD, Kunt T et al. (2000) Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci 98:283–290PubMed
5.
go back to reference Johansson BL, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1151–1158PubMed Johansson BL, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1151–1158PubMed
6.
go back to reference Johansson BL, Pernow J (1999) C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients. Acta Physiol Scand 165:39–44CrossRefPubMed Johansson BL, Pernow J (1999) C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients. Acta Physiol Scand 165:39–44CrossRefPubMed
7.
go back to reference Fernqvist-Forbes E, Johansson BL, Erikson MJ (2001) Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus. Acta Physiol Scand 172:159–165CrossRefPubMed Fernqvist-Forbes E, Johansson BL, Erikson MJ (2001) Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus. Acta Physiol Scand 172:159–165CrossRefPubMed
8.
go back to reference Jensen ME, Messina EJ (1999) C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol 276:H1223–H1228PubMed Jensen ME, Messina EJ (1999) C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol 276:H1223–H1228PubMed
9.
go back to reference Scalia R, Coyle KM, Levine BJ, Booth G, Lefer AM (2000) C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J 14:2357–2364CrossRefPubMed Scalia R, Coyle KM, Levine BJ, Booth G, Lefer AM (2000) C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J 14:2357–2364CrossRefPubMed
10.
go back to reference Young LH, Ikeda Y, Scalia R, Lefer AM (2000) C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 279:H1453–H1459PubMed Young LH, Ikeda Y, Scalia R, Lefer AM (2000) C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 279:H1453–H1459PubMed
11.
go back to reference Govers R, Rabelink TJ (2001) Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280:F193–F206PubMed Govers R, Rabelink TJ (2001) Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280:F193–F206PubMed
12.
go back to reference Fulton D, Gratton JP, Sessa WC (2001) Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J Pharmacol Exp Ther 299:818–824PubMed Fulton D, Gratton JP, Sessa WC (2001) Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J Pharmacol Exp Ther 299:818–824PubMed
13.
go back to reference Venema RC, Sayegh HS, Kent JD, Harrison DG (1996) Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem 271:6435–6440CrossRefPubMed Venema RC, Sayegh HS, Kent JD, Harrison DG (1996) Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem 271:6435–6440CrossRefPubMed
14.
go back to reference Zembowicz A, Tang JL, Wu KK (1995) Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem 270:17006–17010CrossRefPubMed Zembowicz A, Tang JL, Wu KK (1995) Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem 270:17006–17010CrossRefPubMed
15.
go back to reference Cieslik K, Lee CM, Tang JL, Wu KK (1999) Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A. J Biol Chem 274:34669–34675CrossRefPubMed Cieslik K, Lee CM, Tang JL, Wu KK (1999) Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A. J Biol Chem 274:34669–34675CrossRefPubMed
16.
go back to reference Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417–2423PubMed Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417–2423PubMed
17.
go back to reference Purdie KJ, Whitley GS, Johnstone AP, Cartwright JE (2002) Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc Res 54:659–668CrossRefPubMed Purdie KJ, Whitley GS, Johnstone AP, Cartwright JE (2002) Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc Res 54:659–668CrossRefPubMed
18.
go back to reference Ruan J, Xie Q, Hutchinson N, Cho H, Wolfe GC, Nathan C (1996) Inducible nitric oxide synthase requires both the canonical calmodulin-binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca2+. J Biol Chem 271:22679–22686CrossRefPubMed Ruan J, Xie Q, Hutchinson N, Cho H, Wolfe GC, Nathan C (1996) Inducible nitric oxide synthase requires both the canonical calmodulin-binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca2+. J Biol Chem 271:22679–22686CrossRefPubMed
19.
go back to reference Kitamura T, Kimura K, Jung BD et al. (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem J 355:123–129CrossRefPubMed Kitamura T, Kimura K, Jung BD et al. (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem J 355:123–129CrossRefPubMed
20.
go back to reference Grunberger G, Qiang X, Li Z et al. (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247–1257PubMed Grunberger G, Qiang X, Li Z et al. (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247–1257PubMed
21.
go back to reference Kitamura T, Kimura K, Jung BD et al. (2002) Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 366:737–744PubMed Kitamura T, Kimura K, Jung BD et al. (2002) Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 366:737–744PubMed
22.
go back to reference Magee JC, Stone AE, Oldham KT, Guice KS (1994) Isolation, culture, and characterization of rat lung microvascular endothelial cells. Am J Physiol 267:L433–L441PubMed Magee JC, Stone AE, Oldham KT, Guice KS (1994) Isolation, culture, and characterization of rat lung microvascular endothelial cells. Am J Physiol 267:L433–L441PubMed
23.
go back to reference Curtis AS, Renshaw RM (1982) Lymphocyte-endothelial interactions and histocompatibility restriction. Adv Exp Med Biol 149:193–198PubMed Curtis AS, Renshaw RM (1982) Lymphocyte-endothelial interactions and histocompatibility restriction. Adv Exp Med Biol 149:193–198PubMed
24.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
25.
go back to reference Bouloumié A, Schini-Kerth VB, Busse R (1999) Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 41:773–780CrossRefPubMed Bouloumié A, Schini-Kerth VB, Busse R (1999) Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 41:773–780CrossRefPubMed
26.
go back to reference Zheng J, Bird IM, Melsaether AN, Magness RR (1999) Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140:1399–1407PubMed Zheng J, Bird IM, Melsaether AN, Magness RR (1999) Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140:1399–1407PubMed
27.
go back to reference Karantzoulis-Fegaras F, Antoniou H, Lai SL et al. (1999) Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 274:3076–3093CrossRefPubMed Karantzoulis-Fegaras F, Antoniou H, Lai SL et al. (1999) Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 274:3076–3093CrossRefPubMed
28.
go back to reference Wang Q, Pfeiffer GR 2nd, Stevens T, Doerschuk CM (2002) Lung microvascular and arterial endothelial cells differ in their responses to intercellular adhesion molecule-1 ligation. Am J Respir Crit Care Med 166:872–877CrossRefPubMed Wang Q, Pfeiffer GR 2nd, Stevens T, Doerschuk CM (2002) Lung microvascular and arterial endothelial cells differ in their responses to intercellular adhesion molecule-1 ligation. Am J Respir Crit Care Med 166:872–877CrossRefPubMed
29.
go back to reference Montagnani M, Chen H, Barr VA, Quon MJ (2001) Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem 276:30392–30398CrossRefPubMed Montagnani M, Chen H, Barr VA, Quon MJ (2001) Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem 276:30392–30398CrossRefPubMed
30.
go back to reference Tsimaratos M, Roger F, Chabardes D et al. (2003) C-peptide stimulates Na(+),K(+)-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46:124–131PubMed Tsimaratos M, Roger F, Chabardes D et al. (2003) C-peptide stimulates Na(+),K(+)-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46:124–131PubMed
31.
go back to reference Michell BJ, Chen Zp, Tiganis T et al. (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625–17628CrossRefPubMed Michell BJ, Chen Zp, Tiganis T et al. (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625–17628CrossRefPubMed
32.
go back to reference Shafqat J, Juntti-Berggren L, Zhong Z et al. (2002) Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells. Cell Mol Life Sci 59:1185–1189CrossRef Shafqat J, Juntti-Berggren L, Zhong Z et al. (2002) Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells. Cell Mol Life Sci 59:1185–1189CrossRef
33.
go back to reference Johansson J, Ekberg K, Shafqat J et al. (2002) Molecular effects of proinsulin C-peptide. Biochem Biophys Res Commun 295:1035–1040CrossRefPubMed Johansson J, Ekberg K, Shafqat J et al. (2002) Molecular effects of proinsulin C-peptide. Biochem Biophys Res Commun 295:1035–1040CrossRefPubMed
34.
go back to reference Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, Polgar P (2002) Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 193:275–286CrossRefPubMed Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, Polgar P (2002) Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 193:275–286CrossRefPubMed
35.
go back to reference Kimura K, White B, Sidhu A (1995) Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins: Evidence that D-1 dopamine receptors can couple to both Gs and G(o). J Biol Chem 270:14672–14678CrossRefPubMed Kimura K, White B, Sidhu A (1995) Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins: Evidence that D-1 dopamine receptors can couple to both Gs and G(o). J Biol Chem 270:14672–14678CrossRefPubMed
36.
go back to reference Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ (1998) Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 14:241–249CrossRefPubMed Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ (1998) Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 14:241–249CrossRefPubMed
Metadata
Title
Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats
Authors
T. Kitamura
K. Kimura, PhD
K. Makondo
D. T. Furuya
M. Suzuki
T. Yoshida
M. Saito
Publication date
01-12-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1232-3

Other articles of this Issue 12/2003

Diabetologia 12/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.